AstraZeneca halts £200m research investment in Cambridge
AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, UK, according to reports from Reuters.…
News
FDA chief blames decades of regulatory failure for misleading pharma ads
Amneal secures FDA approval for sodium oxybate solution
LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut
AbbVie extends Rinvoq exclusivity by four years after generics settlements
Kashiv signs deal with CRISTÁLIA for Xolair biosimilar in LATAM
GTCR to acquire generic drug maker Zentiva
MSD calls off £1bn UK expansion amid government-big pharma tensions
